title: What is the best antimicrobial treatment for severe community-acquired pneumonia (including the role of steroids and statins and other immunomodulatory agents).
abstract: Community-acquired pneumonia (CAP) is the leading cause of death from infectious diseases in the United States. The mortality rate due to severe CAP has shown little improvement over the past few years, with a rate as high as 50% mainly in patients admitted to intensive care units. Death and adverse outcomes from CAP result from a complex interplay between the pathogen and the host. Several therapies have been tested in patients with severe CAP in recent years. This article reviews recent data regarding different treatments including antimicrobials and adjunctive therapies in patients with severe CAP.
authors: University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
authors: Oriol
authors: O
authors: Sibila
authors: Marcos I
authors: MI
authors: Restrepo
authors: Antonio
authors: A
authors: Anzueto
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D056747:Immunomodulation; D018942:Macrolides / Q000627:therapeutic use; D011014:Pneumonia / Q000188:drug therapy* / Q000276:immunology; D013256:Steroids / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007155:Immunologic Factors; D018942:Macrolides; D013256:Steroids